MedTrace Logo

0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

NCT04403971 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2021-12-14

No results posted yet for this study

Summary

Chlorhexidine is a effective strategy in reducing ventilator associated pneumonia. However, it is unclear if prophylactic 0.12% chlorhexidine oral rinse can reduce the risk of non-ventilator hospital-acquired pneumonia among hospitalized patients.

Conditions

  • Hospital-acquired Pneumonia

Interventions

DRUG

0.12% Chlorhexidine Oral Liquid Product

The intervention group 1 received 10ml 0.12% chlorhexidine solution for oral rinse twice a day.

DRUG

Listerine Oral Liquid Product

The intervention group 2 received 10ml Listerine solution for oral rinse twice a day.

OTHER

Normal Saline Product

The control group received 10ml normal saline for oral rinse twice a day.

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-25
Primary Completion
2020-10-31
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04403971 on ClinicalTrials.gov